SOTALOL - A BETA-BLOCKER WITH UNIQUE ANTIARRHYTHMIC PROPERTIES

[1] A COMPARATIVE STUDY OF SOME CARDIOVASCULAR EFFECTS OF SOTALOL (MJ 1999) AND PROPRANOLOL [J]. LIFE SCIENCES PART 1 PHYSIOLOGY AND PHARMACOLOGY AND PART 2 BIOCHEMISTRY GENERAL AND MOLECULAR BIOLOGY, 1969, 8 (7P1): : 353 - &

[2] MULTICENTER TRIAL OF SOTALOL FOR SUPPRESSION OF FREQUENT, COMPLEX VENTRICULAR ARRHYTHMIAS - A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED EVALUATION OF 2 DOSES [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1986, 8 (04) : 752 - 762

[3] ANTILLA M, 1976, ACTA PHARM TOXICOL C, V39, P118

[4] PHARMACOKINETICS, CENTRAL NERVOUS-SYSTEM UPTAKE, AND LIPID SOLUBILITY OF PROPRANOLOL, ACEBUTOLOL, AND SOTALOL [J]. CARDIOLOGY, 1984, 71 (06) : 307 - 314

[5] EFFECTS OF PARA-SUBSTITUTED BETA-ADRENOCEPTOR BLOCKING-AGENTS AND METHYL-SUBSTITUTED PHENOXYPROPANOLAMINE DERIVATIVES ON MAXIMUM UPSTROKE VELOCITY OF ACTION-POTENTIAL IN GUINEA-PIG PAPILLARY-MUSCLES [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1985, 329 (01) : 77 - 85

[6] COMPARATIVE CHRONOTROPIC ACTIVITY OF BETA-ADRENOCEPTIVE ANTAGONISTS [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1970, 40 (03) : 373 - +

[7] A CASE OF SOTALOL POISONING [J]. IRISH JOURNAL OF MEDICAL SCIENCE, 1982, 151 (04) : 126 - 127

[8] EFFECTS OF THE BETA-ADRENOCEPTOR BLOCKING-AGENT SOTALOL ON CNS - SLEEP, EEG, AND PSYCHOPHYSIOLOGICAL PARAMETERS [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 19 (8-9) : 505 - 512

[9] BENNETT DH, 1982, BRIT HEART J, V47, P521

[10] BENNETT JM, 1985, S AFR MED J, V68, P591

[1] A COMPARATIVE STUDY OF SOME CARDIOVASCULAR EFFECTS OF SOTALOL (MJ 1999) AND PROPRANOLOL [J]. LIFE SCIENCES PART 1 PHYSIOLOGY AND PHARMACOLOGY AND PART 2 BIOCHEMISTRY GENERAL AND MOLECULAR BIOLOGY, 1969, 8 (7P1): : 353 - &

[2] MULTICENTER TRIAL OF SOTALOL FOR SUPPRESSION OF FREQUENT, COMPLEX VENTRICULAR ARRHYTHMIAS - A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED EVALUATION OF 2 DOSES [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1986, 8 (04) : 752 - 762

[3] ANTILLA M, 1976, ACTA PHARM TOXICOL C, V39, P118

[4] PHARMACOKINETICS, CENTRAL NERVOUS-SYSTEM UPTAKE, AND LIPID SOLUBILITY OF PROPRANOLOL, ACEBUTOLOL, AND SOTALOL [J]. CARDIOLOGY, 1984, 71 (06) : 307 - 314

[5] EFFECTS OF PARA-SUBSTITUTED BETA-ADRENOCEPTOR BLOCKING-AGENTS AND METHYL-SUBSTITUTED PHENOXYPROPANOLAMINE DERIVATIVES ON MAXIMUM UPSTROKE VELOCITY OF ACTION-POTENTIAL IN GUINEA-PIG PAPILLARY-MUSCLES [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1985, 329 (01) : 77 - 85

[6] COMPARATIVE CHRONOTROPIC ACTIVITY OF BETA-ADRENOCEPTIVE ANTAGONISTS [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1970, 40 (03) : 373 - +

[7] A CASE OF SOTALOL POISONING [J]. IRISH JOURNAL OF MEDICAL SCIENCE, 1982, 151 (04) : 126 - 127

[8] EFFECTS OF THE BETA-ADRENOCEPTOR BLOCKING-AGENT SOTALOL ON CNS - SLEEP, EEG, AND PSYCHOPHYSIOLOGICAL PARAMETERS [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 19 (8-9) : 505 - 512

[9] BENNETT DH, 1982, BRIT HEART J, V47, P521

[10] BENNETT JM, 1985, S AFR MED J, V68, P591